You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epithelial ovarian cancer (EOC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Ovarian Cancer Trial in Chengdu (Yangzheng Xiaoji, Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • Chengdu, Sichuan, China
    Sicchuan cancer hospital
Nov 30, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

Fallopian Tube Cancer, Peritoneum Cancer, Epithelial Ovarian Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Miami, Florida
    University of Miami
Dec 24, 2021

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Bespoke ctDNA Assay for Recurrence and Treatment Response

Recruiting
  • Ovarian Cancer
  • platinum-sensitive EOC
  • platinum-resistant and rEOC
  • Shanghai, Shanghai, China
    Hao Wen
Jul 5, 2022

HRD and Resistance to PAPPi in EOC Patients

Recruiting
  • Epithelial Ovarian Cancer
  • +6 more
  • Testing of homologous recombination deficiency
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)

Active, not recruiting
  • Ovarian Cancer
  • Etoposide, Cyclophosphamide, Carboplatin
  • Shanghai, Shanghai, China
    Wu Xiaohua
Jul 25, 2022

Platinum-resistant Epithelial Ovarian Cancer Trial in Toronto (Hydroxychloroquine, Itraconazole)

Completed
  • Platinum-resistant Epithelial Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 1, 2021

Ovarian Cancer, Fatigue, Coping Behavior Trial in Boston, Philadelphia (Enhanced Usual Care (EOC), REVITALIZE ACT Intervention)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Enhanced Usual Care (EOC)
  • REVITALIZE ACT Intervention
  • Boston, Massachusetts
  • +1 more
Jun 13, 2022

Ovarian Tumor Epithelial, Homologous Recombination Deficiency, BRCA1 Mutation Trial in Groningen, Leiden, Rotterdam (Functional

Recruiting
  • Ovarian Neoplasm Epithelial
  • +3 more
  • Functional RAD51 assay
  • Olaparib Oral Product
  • Groningen, Netherlands
  • +2 more
Mar 30, 2021

The INFLUENCE of Cytoreduction on PRO in EOC

Recruiting
  • Epithelial Ovarian Cancer
    • Bergen, Norway
    • +2 more
    Aug 31, 2021

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (SG001, Doxorubicin HCl liposome injection)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • SG001
    • Doxorubicin hydrochloride liposome injection
    • (no location specified)
    Jul 20, 2021

    Ovarian Cancer Trial in Bergen, Stavanger (Metformin, Acetylsalicylic acid, Olaparib)

    Recruiting
    • Ovarian Cancer
    • Bergen, Norway
    • +1 more
    Aug 31, 2021

    Epithelial Ovarian Cancer: A Retrospective Study

    Recruiting
    • Epithelial Ovarian Cancer
    • Hematologic features
    • Shanghai, Shanghai, China
      Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
    Oct 16, 2023

    Primary Peritoneal Carcinoma Trial in Baltimore (Tremelimumab, Olaparib)

    Terminated
    • Primary Peritoneal Carcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Apr 9, 2021

    Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • liquid biopsy
    • Aviano, Italy
      Centro di Riferimento Oncologico (CRO), IRCCS
    May 16, 2023

    The Immune Landscape of Epithelial Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • Collection of tumor samples, blood and vaginal and rectal swabs
    • Bellinzona, Switzerland
      Oncology Institute of Southern Switzerland
    Aug 2, 2023

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)

    Not yet recruiting
    • Recurrent Ovarian Cancer
    • +2 more
    • (no location specified)
    Jul 26, 2022

    Epithelial Ovarian Cancer- Staging and Response to Chemotherapy

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
      • Turku, Finland
        Turku University hospital
      Apr 26, 2022

      Epithelial Ovarian Cancer Trial in Hangzhou (Pamiparib)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Aug 4, 2022

      Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Ovarian Carcinoma
      • XP-DC vaccinations
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Mar 6, 2023

      Epithelial Ovarian Cancer Trial in Leiden ([18F]fluoro-PEG-folate PET/CT scan)

      Recruiting
      • Epithelial Ovarian Cancer
      • [18F]fluoro-PEG-folate PET/CT scan
      • Leiden, Zuid-holland, Netherlands
        Leiden University Medical Center
      Aug 17, 2022

      A Training Set for the HRD Model in EOC

      Recruiting
      • Epithelial Ovarian Cancer
      • +5 more
      • Homologous recombination deficiency model
      • Beijing, Beijing, China
        Lei Li
      Dec 2, 2020